Kymera Therapeutics, Inc. - COM (KYMR)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
67.4M
Holdings value Q2 2024
$2.01B
Value change Q2 2024
+$9.92M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
152
Number of buys Q2 2024
33
Number of sells Q2 2024
-21
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.04M $96.6M +$25.7M $47.33 49
2024 Q2 67.4M $2.01B +$9.92M $29.85 152
2024 Q1 67M $2.7B +$299M $40.20 157
2023 Q4 60.4M $1.54B +$91.9M $25.46 132
2023 Q3 57.2M $795M -$21.4M $13.90 118
2023 Q2 58.2M $1.34B +$29.1M $22.99 123
2023 Q1 56.8M $1.68B +$23.1M $29.63 123
2022 Q4 56.1M $1.4B +$97.6M $24.96 116
2022 Q3 52.8M $1.15B +$28.3M $21.77 117
2022 Q2 49.4M $973M +$16.5M $19.69 99
2022 Q1 45.7M $1.93B +$62M $42.32 126
2021 Q4 43M $2.73B +$129M $63.49 124
2021 Q3 34.6M $2.03B +$492M $58.74 115
2021 Q2 26.5M $1.28B +$188M $48.50 109
2021 Q1 22.2M $862M +$92.7M $38.86 94
2020 Q4 20.3M $1.25B +$53M $62.00 74
2020 Q3 16.8M $543M +$543M $32.31 51